Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Формирование полипозного синусита: значимость эозинофильного воспаления
Формирование полипозного синусита: значимость эозинофильного воспаления
Туровский А.Б., Бондарева Г.П., Семкина О.В. Формирование полипозного синусита: значимость эозинофильного воспаления. Consilium Medicum. 2014; 16 (3): 63–67.
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Полный текст
Список литературы
1. Лопатин А.С. Лечение полипозного риносинусита. Атфосфера. Пульмонология и аллергология. 2002; 3: 6–8.
2. Пискунов Г.З. Причины роста распространенности заболеваний носа и околоносовых пазух. Рос. ринология. 2009; 2: 7–9.
3. Пухлик С.М. Полипозный риносинусит: подходы к лечению. Ринологія. 2008; 1: 48–51.
4. Bachert C, Gevaert P, Holtappels G et al. Total and specific IgE in nasal polyps is related to local eosinophilic inflammation. J Allergy Clin Immunol 2001; 107: 607–14.
5. Bachert C, Wagenmann M, Hauser U et al. IL-5 synthesis is upregulated in human nasal polyp tissue. J Allergy Clin Immunol 1997; 99: 837–42.
6. Bradley DT, Kountakis SE. Role of interleukins and transforming growth factor-beta in chronic rhinosinusitis and nasal polyposis. Laryngoscope 2005; 115: 684–6.
7. Cao PP, Li HB, Wang BF et al. Distinct immunopathologic characteristics of various types of chronic rhinosinusitis in adult Chinese. J Allergy Clin Immunol 2009; 124: 478–84.
8. Corriveau M, Zhang N, Holtappels G et al. Detection of Staphylococcus aureus in nasal tissue with peptide nucleic acid-fluorescence in situ hybridization. Am J Rhinol Allergy 2009; 23: 461–5.
9. EPOS (European Position Paper on Rhinosinusitis and Nasal Polyposis). Rhinology 2007; Suppl. 20: 1–30.
10. Gevaert P, Nouri-Aria KT, Wu H et al. Local receptor revision and class switching to IgE in chronic rhinosinusitis with nasal polyps. Allergy 2013; 68: 55–63.
11. Jareonchasri P, Bunnag C, Muangsomboon S et al. Clinical and Histopathological Classification of Nasal Polyps in Thais. Siriraj Hosp Gaz 2002; 54: 689–97.
12. Kim JW, Hong SL, Kim YK et al. Histological and immunological features of non-eosinophilic nasal polyps. Otolaryngol Head Neck Surg 2007; 137: 925–30.
13. Kirtsreesakul V, Naclerio RM. Role of allergy in rhinosinusitis. Curr Opin Allergy Clin Immunol 2004; 4: 17–23.
14. Larsen PL, Tos M. Origin of nasal polyps: an endoscopic autopsy study. Laryngoscope 2004; 114: 710–9.
15. Pawliczak R, Lewandowska-Polak A, Kowalski ML. Pathogenesis of Nasal Polyps: An Update. Curr Allergy Asthma Rep 2005; 5: 463–71.
16. Pawankar R, Nonaka M. Inflammatory Mechanisms and Remodeling in Chronic Rhinosinusitis and Nasal Polyps. Curr Allergy Asthma Rep 2007; 7: 202–8.
17 Pérez-Novo CA, Watelet JB, Claeys C et al. Prostaglandin, leukotriene, and lipoxin balance in chronic rhinosinusitis with and without nasal polyposis. J Allergy Clin Immunol 2005; 115: 1189–96.
18. Rinia AB, Kostamo K, Ebbens FA et al. Nasal polyposis: a cellular-based approach to answering questions. Allergy 2007; 62: 348–58.
19. Settipane GA. Epidemiology of nasal polyps. Allergy Asthma Proc 1996; 17: 231–6.
20. Tantilipikorn P, Bunnag C, Nan Z, Bachert C. Staphylococcus aureus superantigens and their role in eosinophilic nasal polyp disease. Asian Pac J Allergy Immunol 2012; 30: 171–6.
21. Van Zele T, Claeys S, Gevaert P et al. Differentiation of chronic sinus diseases by measurement of inflammatory mediators. Allergy 2006; 61: 1280–9.
22. Van Zele T, Gevaert P, Watelet JB et al. Staphylococcus aureus colonization and IgE antibody formation to enterotoxins is increased in nasal polyposis. J Allergy Clin Immunol 2004; 114: 981–3.
23. Zhang N, van Zele T, Perez-Novo C et al. Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus disease. J Allergy Clin Immunol 2008; 122: 961–8.
2. Пискунов Г.З. Причины роста распространенности заболеваний носа и околоносовых пазух. Рос. ринология. 2009; 2: 7–9.
3. Пухлик С.М. Полипозный риносинусит: подходы к лечению. Ринологія. 2008; 1: 48–51.
4. Bachert C, Gevaert P, Holtappels G et al. Total and specific IgE in nasal polyps is related to local eosinophilic inflammation. J Allergy Clin Immunol 2001; 107: 607–14.
5. Bachert C, Wagenmann M, Hauser U et al. IL-5 synthesis is upregulated in human nasal polyp tissue. J Allergy Clin Immunol 1997; 99: 837–42.
6. Bradley DT, Kountakis SE. Role of interleukins and transforming growth factor-beta in chronic rhinosinusitis and nasal polyposis. Laryngoscope 2005; 115: 684–6.
7. Cao PP, Li HB, Wang BF et al. Distinct immunopathologic characteristics of various types of chronic rhinosinusitis in adult Chinese. J Allergy Clin Immunol 2009; 124: 478–84.
8. Corriveau M, Zhang N, Holtappels G et al. Detection of Staphylococcus aureus in nasal tissue with peptide nucleic acid-fluorescence in situ hybridization. Am J Rhinol Allergy 2009; 23: 461–5.
9. EPOS (European Position Paper on Rhinosinusitis and Nasal Polyposis). Rhinology 2007; Suppl. 20: 1–30.
10. Gevaert P, Nouri-Aria KT, Wu H et al. Local receptor revision and class switching to IgE in chronic rhinosinusitis with nasal polyps. Allergy 2013; 68: 55–63.
11. Jareonchasri P, Bunnag C, Muangsomboon S et al. Clinical and Histopathological Classification of Nasal Polyps in Thais. Siriraj Hosp Gaz 2002; 54: 689–97.
12. Kim JW, Hong SL, Kim YK et al. Histological and immunological features of non-eosinophilic nasal polyps. Otolaryngol Head Neck Surg 2007; 137: 925–30.
13. Kirtsreesakul V, Naclerio RM. Role of allergy in rhinosinusitis. Curr Opin Allergy Clin Immunol 2004; 4: 17–23.
14. Larsen PL, Tos M. Origin of nasal polyps: an endoscopic autopsy study. Laryngoscope 2004; 114: 710–9.
15. Pawliczak R, Lewandowska-Polak A, Kowalski ML. Pathogenesis of Nasal Polyps: An Update. Curr Allergy Asthma Rep 2005; 5: 463–71.
16. Pawankar R, Nonaka M. Inflammatory Mechanisms and Remodeling in Chronic Rhinosinusitis and Nasal Polyps. Curr Allergy Asthma Rep 2007; 7: 202–8.
17 Pérez-Novo CA, Watelet JB, Claeys C et al. Prostaglandin, leukotriene, and lipoxin balance in chronic rhinosinusitis with and without nasal polyposis. J Allergy Clin Immunol 2005; 115: 1189–96.
18. Rinia AB, Kostamo K, Ebbens FA et al. Nasal polyposis: a cellular-based approach to answering questions. Allergy 2007; 62: 348–58.
19. Settipane GA. Epidemiology of nasal polyps. Allergy Asthma Proc 1996; 17: 231–6.
20. Tantilipikorn P, Bunnag C, Nan Z, Bachert C. Staphylococcus aureus superantigens and their role in eosinophilic nasal polyp disease. Asian Pac J Allergy Immunol 2012; 30: 171–6.
21. Van Zele T, Claeys S, Gevaert P et al. Differentiation of chronic sinus diseases by measurement of inflammatory mediators. Allergy 2006; 61: 1280–9.
22. Van Zele T, Gevaert P, Watelet JB et al. Staphylococcus aureus colonization and IgE antibody formation to enterotoxins is increased in nasal polyposis. J Allergy Clin Immunol 2004; 114: 981–3.
23. Zhang N, van Zele T, Perez-Novo C et al. Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus disease. J Allergy Clin Immunol 2008; 122: 961–8.
Авторы
А.Б.Туровский, Г.П.Бондарева, О.В.Семкина
ГБУЗ Московский научно-практический центр оториноларингологии им Л.И.Свержевского Департамента здравоохранения г. Москвы
ГБУЗ Московский научно-практический центр оториноларингологии им Л.И.Свержевского Департамента здравоохранения г. Москвы
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.